Literature DB >> 25034990

Re: Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time.

Samir S Taneja.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25034990     DOI: 10.1016/j.juro.2014.05.077

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  1 in total

1.  Ezrin expression in circulating tumor cells is a predictor of prostate cancer metastasis.

Authors:  Zheng Chen; Jue Wang; Yangbai Lu; Caiyong Lai; Lijun Qu; Yumin Zhuo
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.